Affiliations: Centre for Oral Immunobiology and Regenerative Medicine, Dental Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK
Correspondence:
[*]
Corresponding author: Angray S. Kang, Centre for Oral Immunobiology and Regenerative Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. E-mail: a.s.kang@qmul.ac.uk. ORCID: 0000-0002-4672-4114.
Abstract: Monoclonal antibody biologics have significantly transformed the therapeutic landscape within the biopharmaceutical industry, partly due to the utilisation of discovery technologies such as the hybridoma method and phage display. While these established platforms have streamlined the development process to date, their reliance on cell transformation for antibody identification faces limitations related to library diversification and the constraints of host cell physiology. Cell-free systems like ribosome display offer a complementary approach, enabling antibody selection in a completely in vitro setting while harnessing enriched cellular molecular machinery. This review aims to provide an overview of the fundamental principles underlying the ribosome display method and its potential for advancing antibody discovery and development.
